AU7031798A - Use of pivagabin to prepare pharmaceutical compositions - Google Patents

Use of pivagabin to prepare pharmaceutical compositions

Info

Publication number
AU7031798A
AU7031798A AU70317/98A AU7031798A AU7031798A AU 7031798 A AU7031798 A AU 7031798A AU 70317/98 A AU70317/98 A AU 70317/98A AU 7031798 A AU7031798 A AU 7031798A AU 7031798 A AU7031798 A AU 7031798A
Authority
AU
Australia
Prior art keywords
pivagabin
pharmaceutical compositions
prepare pharmaceutical
prepare
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70317/98A
Inventor
Gaetano Esposito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Publication of AU7031798A publication Critical patent/AU7031798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
AU70317/98A 1997-03-03 1998-02-25 Use of pivagabin to prepare pharmaceutical compositions Abandoned AU7031798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97MI000456A IT1290003B1 (en) 1997-03-03 1997-03-03 USE OF PIVAGABINA TO PREPARE PHARMACEUTICAL COMPOSITIONS
ITMI97A0456 1997-03-03
PCT/EP1998/001279 WO1998038988A1 (en) 1997-03-03 1998-02-25 Use of pivagabin to prepare pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU7031798A true AU7031798A (en) 1998-09-22

Family

ID=11376246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70317/98A Abandoned AU7031798A (en) 1997-03-03 1998-02-25 Use of pivagabin to prepare pharmaceutical compositions

Country Status (7)

Country Link
JP (1) JP2001513800A (en)
AR (1) AR011907A1 (en)
AU (1) AU7031798A (en)
IL (1) IL131355A0 (en)
IT (1) IT1290003B1 (en)
WO (1) WO1998038988A1 (en)
ZA (1) ZA981729B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031473A1 (en) * 2000-11-20 2003-09-24 Lundbeck & Co As H GABA INTENSIFIERS IN THE TREATMENT OF DISEASES RELATED TO A REDUCED NEUROSTEROID ACTIVITY
AU2007325686A1 (en) * 2006-11-30 2008-06-05 Cenerx Biopharma, Inc. Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
JP6835707B2 (en) * 2016-04-05 2021-02-24 株式会社Moresco Oxic acid compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202402B (en) * 1977-06-01 1989-02-09 Galzigna Lauro Hydrophobic derivs. of 4-aminobutyric acid

Also Published As

Publication number Publication date
ZA981729B (en) 1998-08-28
WO1998038988A1 (en) 1998-09-11
IT1290003B1 (en) 1998-10-19
AR011907A1 (en) 2000-09-13
ITMI970456A1 (en) 1998-09-03
IL131355A0 (en) 2001-01-28
JP2001513800A (en) 2001-09-04

Similar Documents

Publication Publication Date Title
AU3445697A (en) New use of xylitol and pharmaceutical compositions therefor
AU1307299A (en) Stable pharmaceutical compositions including ascorbic acid and methods of using same
AU6513298A (en) Therapeutic compositions
HUP0002183A3 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
AU1157599A (en) Pyrimidinone compounds and pharmaceutical compositions containing them
AU6740298A (en) Pharmaceutical composition
ZA986437B (en) Derivatives of acyl-piperazinyl-pyrimidines their preparation and application as medicaments
HUP0004071A3 (en) Pharmaceutical compositions comprising prostaglandin derivatives
AU8107998A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
AU8168998A (en) Synthesis of dihydrohonokiol compositions
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU9343098A (en) Pharmaceutical composition
AU3191597A (en) Novel medicinal compositions of hydropyridines
AU1718301A (en) Use of sugar compositions
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
AU7031798A (en) Use of pivagabin to prepare pharmaceutical compositions
HUP9901969A3 (en) Use of n-mercaptoalkanoyl-cysteine derivatives for the preparation of pharmaceutical compositions traiting ischemia
AU7647798A (en) Preparation of mibefradil i
AU8102498A (en) Preparation of diaryl-benzopyrans
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
AU7772698A (en) Use of indolamines as antithrombotic medicine
AU3987997A (en) Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof
AU6349599A (en) Use of xanthan gums for preparing pharmaceutical compositions